SJS Investment Consulting »

Xenon Pharmaceuticals shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2024-03-31 $216 5 43.20
2023-12-31 $231 5 46.20
2023-09-30 $102 3 34.33
2023-06-30 $77 2 38.50

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Hormel Foods Corporation (HRL)
Eli Lilly & Co. (LLY)
Dimensional Etf Trust Short Duration F (DFSD)
Apple (AAPL)
Dimensional Etf Trust World Ex Us Core (DFAX)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Core Fixed Incom (DFCF)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Dimensional Etf Trust Global Real Est (DFGR)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Emerging Mkts Co (DFEM)

View all positions for SJS Investment Consulting

Top funds holding Xenon Pharmaceuticals

venBio Select Advisor
Wellington Management Company
Commodore Capital
Paradigm Biocapital Advisors
Braidwell
First Light Asset Management
Alliancebernstein
Marshall Wace
Citadel Advisors
Perceptive Advisors
Baker Bros. Advisors
Henderson Group
BVF
Point72 Asset Management
Avidity Partners Management

View all funds holding Xenon Pharmaceuticals